Stock listing
LSE:0J4V Heron Therapeutics, Inc. Share Price
UK listing (LSE) of Heron Therapeutics, Inc. · home listing NASDAQ:HRTX
Follow Heron Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · LSE:0J4V
$0.302 USD -0.047 (-13.4%)
Close on Nov 16, 2026
- Day range
- $0.300 – $0.330 USDNov 16, 2026
- Volume
- 19,975 sharesNov 16, 2026
- 52-week range
- $0.261 – $1.570 USDLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- $33,584 USDMedian day 11,058 shares · last 3 months, Aug 17, 2026 – Nov 11, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HRTX · Home | $0.284 USD | -0.026 (-8.4%) | 5,907,252 | $0.303 | $0.330 | $0.268 | $0.311 | Close on Nov 16, 2026 |
| LSE:0J4V | $0.302 USD | -0.047 (-13.4%) | 19,975 | $0.320 | $0.330 | $0.300 | $0.349 | Close on Nov 16, 2026 |
| Frankfurt:AXD2 | €0.285 EUR | -0.005 (-1.6%) | — | €0.285 | €0.285 | €0.285 | €0.290 | Close on Nov 16, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 11, 2026 · LSE:0J4V · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.349 | -0.015 | -4.1% | $0.350 | $0.373 | $0.340 | 43,314 | |
| $0.364 | -0.016 | -4.3% | $0.385 | $0.412 | $0.340 | 196,278 | |
| $0.380 | +0.089 | +30.4% | $0.420 | $0.462 | $0.311 | 3,505,209 | |
| $0.292 | +0.021 | +7.9% | $0.290 | $0.292 | $0.280 | 3,357 | |
| $0.270 | -0.024 | -8.3% | $0.300 | $0.300 | $0.270 | 1,915 | |
| $0.295 | +0.003 | +0.9% | $0.298 | $0.298 | $0.293 | 2,163 | |
| $0.292 | +0.017 | +6.1% | $0.300 | $0.300 | $0.292 | 4,821 | |
| $0.275 | -0.008 | -2.9% | $0.280 | $0.280 | $0.275 | 6,277 | |
| $0.283 | -0.015 | -4.9% | $0.284 | $0.284 | $0.280 | 670 | |
| $0.298 | -0.010 | -3.2% | $0.306 | $0.306 | $0.298 | 4,822 | |
| $0.308 | +0.019 | +6.7% | $0.308 | $0.308 | $0.308 | 108 | |
| $0.289 | +0.003 | +1.1% | $0.286 | $0.290 | $0.285 | 1,790 | |
| $0.286 | -0.015 | -4.8% | $0.288 | $0.289 | $0.286 | 6,877 | |
| $0.300 | -0.034 | -10.2% | $0.335 | $0.335 | $0.298 | 7,367 | |
| $0.334 | -0.048 | -12.6% | $0.375 | $0.375 | $0.334 | 1,591 | |
| $0.382 | +0.016 | +4.4% | $0.359 | $0.382 | $0.359 | 1,523 | |
| $0.366 | +0.009 | +2.5% | $0.361 | $0.370 | $0.361 | 17,521 | |
| $0.357 | -0.015 | -4.1% | $0.357 | $0.357 | $0.354 | 578 | |
| $0.372 | -0.003 | -0.9% | $0.350 | $0.380 | $0.350 | 10,941 | |
| $0.375 | -0.021 | -5.2% | $0.385 | $0.385 | $0.363 | 24,607 | |
| $0.396 | +0.009 | +2.3% | $0.412 | $0.425 | $0.396 | 1,183 | |
| $0.387 | -0.016 | -3.9% | $0.410 | $0.415 | $0.385 | 3,660 | |
| $0.403 | +0.035 | +9.4% | $0.364 | $0.408 | $0.360 | 14,241 | |
| $0.368 | -0.007 | -1.9% | $0.360 | $0.384 | $0.360 | 4,651 | |
| $0.375 | +0.040 | +11.8% | $0.330 | $0.375 | $0.323 | 12,926 | |
| $0.336 | -0.030 | -8.1% | $0.370 | $0.370 | $0.334 | 22,437 | |
| $0.365 | -0.010 | -2.6% | $0.331 | $0.367 | $0.331 | 2,559 | |
| $0.375 | +0.025 | +7.2% | $0.350 | $0.395 | $0.350 | 7,292 | |
| $0.350 | +0.018 | +5.4% | $0.310 | $0.350 | $0.310 | 20,841 | |
| $0.332 | +0.016 | +5.1% | $0.300 | $0.339 | $0.298 | 79,802 | |
| $0.316 | +0.032 | +11.1% | $0.293 | $0.316 | $0.293 | 40,207 | |
| $0.284 | -0.012 | -4.1% | $0.291 | $0.294 | $0.282 | 319 | |
| $0.297 | +0.007 | +2.3% | $0.293 | $0.297 | $0.293 | 3,011 | |
| $0.290 | +0.001 | +0.2% | $0.297 | $0.297 | $0.290 | 2,492 | |
| $0.289 | -0.009 | -3.0% | $0.300 | $0.300 | $0.289 | 20,620 | |
| $0.298 | +0.033 | +12.5% | $0.280 | $0.300 | $0.270 | 124,522 | |
| $0.265 | -0.047 | -15.2% | $0.320 | $0.320 | $0.261 | 74,584 | |
| $0.313 | -0.001 | -0.2% | $0.320 | $0.322 | $0.313 | 10,999 | |
| $0.313 | -0.006 | -1.8% | $0.323 | $0.325 | $0.313 | 1,463 | |
| $0.319 | +0.013 | +4.2% | $0.317 | $0.319 | $0.317 | 27,627 | |
| $0.306 | -0.007 | -2.2% | $0.306 | $0.311 | $0.306 | 16,590 | |
| $0.313 | -0.014 | -4.1% | $0.316 | $0.322 | $0.308 | 8,413 | |
| $0.327 | +0.003 | +0.9% | $0.331 | $0.336 | $0.327 | 432 | |
| $0.324 | -0.010 | -2.9% | $0.328 | $0.328 | $0.324 | 420 | |
| $0.333 | -0.007 | -2.1% | $0.344 | $0.344 | $0.330 | 32,198 | |
| $0.340 | +0.002 | +0.7% | $0.345 | $0.360 | $0.340 | 15,132 | |
| $0.338 | +0.019 | +5.9% | $0.330 | $0.351 | $0.330 | 13,512 | |
| $0.320 | +0.009 | +2.8% | $0.316 | $0.320 | $0.316 | 11,117 | |
| $0.311 | +0.004 | +1.2% | $0.312 | $0.315 | $0.311 | 10,886 | |
| $0.307 | -0.018 | -5.4% | $0.318 | $0.320 | $0.303 | 44,284 | |
| $0.324 | +0.011 | +3.6% | $0.335 | $0.340 | $0.318 | 7,576 | |
| $0.313 | +0.006 | +2.1% | $0.310 | $0.325 | $0.310 | 63,767 | |
| $0.307 | -0.016 | -4.9% | $0.320 | $0.320 | $0.304 | 144,758 | |
| $0.322 | +0.004 | +1.4% | $0.327 | $0.330 | $0.318 | 70,026 | |
| $0.318 | +0.005 | +1.5% | $0.320 | $0.320 | $0.302 | 124,349 | |
| $0.313 | +0.012 | +4.0% | $0.310 | $0.331 | $0.300 | 311,930 | |
| $0.301 | -0.012 | -4.0% | $0.320 | $0.320 | $0.300 | 135,488 | |
| $0.314 | +0.012 | +4.1% | $0.310 | $0.320 | $0.305 | 121,866 | |
| $0.301 | -0.013 | -4.1% | $0.313 | $0.313 | $0.301 | 115,177 | |
| $0.314 | -0.016 | -4.8% | $0.350 | $0.350 | $0.314 | 77,135 |
- Ticker
- LSE:0J4V
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Nov 9, 2026
Heron Therapeutics Announces Third Quarter 2026 Financial Results
Latest earnings call · Aug 10, 2026
Heron Therapeutics (NASDAQ:HRTX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 11, 2026
Q1 2026 Earnings Presentation
Earnings · 23 slides
Calls
Replays
Heron Therapeutics (NASDAQ:HRTX) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 8:30 AM ET
Watch TranscriptHeron Therapeutics (NASDAQ:HRTX) Q1 2026 Earnings Call
Mon, May 11, 2026 · 8:30 AM ET
Watch TranscriptHeron Therapeutics (NASDAQ:HRTX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Heron Therapeutics Announces Third Quarter 2026 Financial Results
Nov 9, 2026
Closed $0.38 (+30.4%) on Nov 9, 2026
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
Nov 9, 2026
Closed $0.38 (+30.4%) on Nov 9, 2026
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Oct 26, 2026
Closed $0.308 (+6.7%) on Oct 28, 2026
Heron Therapeutics Announces Second Quarter 2026 Financial Results
Aug 10, 2026
Closed $0.365 (-24.4%) on Aug 10, 2026
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
Jul 27, 2026
Closed $0.461 (+1.9%) on Jul 27, 2026
U.S. District Court Issues Decision Regarding CINVANTI® Patents
Jun 2, 2026
Closed $0.50 (-40.1%) on Jun 2, 2026
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
May 11, 2026
Closed $0.954 (-22.7%) on May 11, 2026
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
Apr 27, 2026
Closed $1.21 (+2.5%) on Apr 28, 2026
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
Feb 26, 2026
Closed $1.19 (+10.2%) on Feb 26, 2026
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
Feb 17, 2026
Closed $1.21 (+3.9%) on Feb 17, 2026
Financings
5.0% senior convertible notes due 2031
Aug 8, 2025
Announced: US$35M · Leerink Partners
Dealers: Leerink Partners
Use of proceeds: Retire prior convertible notes and the working capital facility, and provide working capital for commercial and development initiatives
Private placement of common and preferred equity
Aug 8, 2025
Announced: US$27.7M · Leerink Partners
Dealers: Leerink Partners (lead)
Use of proceeds: Retire prior convertible notes and the working capital facility, and provide working capital for commercial and development initiatives
Decks
Q1 2026 Earnings Presentation
Earnings · 23 slides · May 11, 2026
Q4 2025 Earnings Presentation
Earnings · 15 slides · Feb 26, 2026
Q2 2025 Earnings Presentation
Earnings · 16 slides · Aug 11, 2025
Q1 2025 Earnings Presentation
Earnings · 15 slides · May 6, 2025
Heron Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 12 in the last 12 months · 146 in all · newest Nov 9, 2026 · oldest 2019
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 10, 2026
- Decks
- 62 decks · latest May 11, 2026
Where Heron Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HRTX · Home listing | NASDAQ | United States | USD |
| BOATS:HRTX | BOATS | United States | USD |
| Lang & Schwarz:A1XB6K | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1XB6K | LS Exchange | Germany | EUR |
| LSE:0J4V · This page | LSE | United Kingdom | USD |
| Stuttgart:AXD2 | Stuttgart | Germany | EUR |
| gettex:AXD2 | gettex | Germany | EUR |
| Dusseldorf:AXD2 | Dusseldorf | Germany | EUR |
| Frankfurt:AXD2 | Frankfurt | Germany | EUR |
| Tradegate:AXD2 | Tradegate | Germany | EUR |
| BX Swiss:AXD2 | BX Swiss | Switzerland | CHF |
| Munich:AXD2 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Heron Therapeutics, Inc.